Sara Arciniegas Ruiz, DVM
Assistant Professor of Veterinary Physiology
Biomedical Sciences
sarciniegas@rossvet.edu.kn
Dr. Sara Arciniegas Ruiz is a Doctor of Veterinary Medicine with specialization in small animal internal medicine, bringing several years of experience in clinical practice with dogs and cats. She holds both a Master’s degree and a PhD in Physiology and Pharmacology, awarded with Honorific Mention.
Over the past eleven years, Dr. Arciniegas Ruiz has led biomedical and preclinical research programs across academia, biotechnology companies, and contract research organizations (CROs) in the Americas, Europe, and the Middle East. Her work has focused on elucidating pathophysiological mechanisms and translating these insights into drug development strategies, with particular emphasis on neuroscience, endocrinology, and metabolic disorders.
As a scientific leader, she is recognized for integrating translational research across species and for designing and implementing complex experimental models to evaluate novel therapeutic approaches. Her career reflects a strong commitment to scientific rigor, innovation, and interdisciplinary collaboration.
Dr. Arciniegas Ruiz has contributed to research, teaching, and professional development at internationally recognized institutions, including the University of Barcelona, Tel Aviv University, Universidad Nacional de Colombia, Universidad Nacional Autónoma de México (UNAM), Universidad de Buenos Aires, Universidad del Valle de México, and North Carolina State University, among others. She has received multiple competitive grants and scholarships, actively publishes in peer-reviewed international journals, is listed as an inventor on several patents, and regularly presents her work at leading scientific conferences. She also supervises students and early-career researchers.
In addition to her academic and research activities, Dr. Arciniegas Ruiz is deeply committed to mentoring future veterinary and biomedical professionals, fostering collaborative research environments, and strengthening the global impact of translational science. She is also actively engaged in community service, promoting science education, animal health and welfare, and public outreach initiatives.
Doctor of Veterinary Medicine (DVM)
Universidad Nacional de Colombia | 2003–2009Master of Science (MSc) in Physiology and Pharmacology
Universidad Nacional Autónoma de México (UNAM), Faculty of Veterinary Medicine | 2012–2014Doctor of Science (DSc) in Physiology and Pharmacology
Universidad Nacional Autónoma de México (UNAM), Faculty of Veterinary Medicine | 2014–2018
Translational and Preclinical Sciences / Drug Development and Pharmacology Animal Welfare
2023. Contextual fear response is modulated by M-type K⁺ channels and is associated with subtle structural changes of the axon initial segment in hippocampal GABAergic neurons. AIMS Neuroscience, 10(1), 33–51.
2022. An exercise-induced metabolic shield in distant organs blocks cancer progression and metastatic dissemination. Cancer Research, 82(22), 4164–4178.
2022. Prospects in GSK-3 signaling: From cellular regulation to disease therapy. Cells, 11(10), 1618.
2022. Glycogen synthase kinase-3 inhibitors: Preclinical and clinical focus on CNS – A decade onward. Frontiers in Molecular Neuroscience, 14.
2022. GSK-3 in Huntington’s disease. Journal of Neurochemistry, 162(S1), 69–70.
2020. Discovery and design of novel small-molecule GSK-3 inhibitors targeting the substrate-binding site. International Journal of Molecular Sciences, 21, 8709.
2020. Comparison of glucose response of flexible liposomes loaded with insulin using different surfactants in an experimental diabetes model. Letters in Drug Design & Discovery, 17, 1–12.
2019. Long-acting oral formulation of doxycycline for dogs: In vitro–in vivo correlation studies. Indian Journal of Pharmaceutical Sciences, 81(4), 608–617.
2019. Lipid domains in LB films and giant vesicles to study GBV-C peptide interaction in the context of HIV-1 fusion peptide inhibition. Colloids and Surfaces A, 578, 1–8.
2019. In vitro and in vivo characterization of insulin nanocarriers based on flexible liposomes designed for oral administration. Letters in Drug Design & Discovery, 16, 1–15.
2015. Comparative pharmacokinetics of a new long-acting oral formulation of doxycycline hyclate: A canine clinical trial. European Journal of Pharmaceutical Sciences, 80, 9–15.
